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Abstract
Visual function abnormalities are common in people living with HIV disease (PLWH) without retinitis, even after
improvement in immune status. Abnormalities such as reduced contrast sensitivity, altered color vision, peripheral visual
field loss, and electrophysiological changes are related to a combination of retinal dysfunctions, involving inner and outer
retinal structures. The standard protocol for testing vision performance in clinical practice is the Early Treatment Diabetic
Retinopathy Study (ETDRS) chart. However, this method poorly correlates with activities of daily living that require patients
to assess visual stimuli in multiple light/contrast conditions, and with limited time. We utilized a novel interactive computer
program (Central Vision Analyzer) to analyze vision performance in PLWH under a variety of light/contrast conditions that
simulate stressful and real-world environments. The program tests vision in a time-dependent way that we believe better
correlates with daily living activities than the non-timed ETDRS chart. We also aimed to correlate visual scores with retinal
neuro-fiber layer thickness on optical coherence tomography. Here we show that visual acuity is more affected in PLWH in
comparison to HIV-seronegative controls in varying contrast and luminance, especially if the nadir CD4+ T-cell count was
lower than 100 cells/mm3. Visual impairment reflects the loss of retinal nerve fiber layer thickness especially of the temporal-
inferior sector. In PLWH the ETDRS chart test led to better visual acuity compared to the Central Vision Analyzer equivalent
test, likely because patients had indefinite time to guess the letters. This study confirms and strengthens the finding that
visual function is affected in PLWH even in absence of retinitis, since we found that the HIV serostatus is the best predictor
of visual loss. The Central Vision Analyzer may be useful in the diagnosis of subclinical HIV-associated visual loss in multiple
light/contrast conditions, and may offer better understanding of this entity called ‘‘neuroretinal disorder’’.
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Introduction
Visual function abnormalities are common in people living with
human immunodeficiency virus (HIV) disease (PLWH) without
retinitis, even after improvement in immune status with antiret-
roviral therapy (ART). [1,2] Abnormalities include reduced
contrast sensitivity, altered color vision, peripheral visual field loss
and electrophysiological changes.[3–9] These changes in visual
function are thought to be caused by HIV-associated ‘‘neuror-
etinal disorder,’’ which is characterized by damage in the retinal
nerve fiber layer (RNFL), as detected by optical coherence
tomography (OCT), most likely due to microinfarctions and
microangiopathy. [10] Although the exact pathogenesis of HIV-
related microangiopathy remains uncertain, several hypotheses
have been reported including direct HIV infection of vascular
endothelial cells, damage from immune complexes, and rheolog-
ical abnormalities. [11] Moreover, recent data from our group
showed dysfunction of the outer retinal layers, especially photo-
receptors and retinal pigment epithelium, in autopsy eyes of HIV-
seropositive donors. [12] Therefore, there may be a second
separate mechanism of vision dysfunction in these eyes.
Since their introduction to clinical practice, the Snellen chart
test and the more recent Early Treatment Diabetic Retinopathy
Study (ETDRS) chart test have been the standard protocol for
testing best-corrected visual acuity (BCVA). [13] However, these
tests are unable to detect subtle visual loss, especially under low
contrast or glare conditions. Indeed, it is generally recognized that
the ETDRS chart test poorly correlates with activities of daily
living [14] (such as driving at night or playing sports outside), since
it’s not time-dependent, and as it allows an evaluation of the
BCVA only in a pre-determined single high-contrast glare
environment. [15] If the widely used ETDRS chart test is poorly
reliable in evaluating BCVA in other contrast or luminance
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conditions for normal eyes, this may be also worse for PLWH.
Indeed, these patients have a poor low-contrast visual performance
– even without any retinitis [2] – and can also have poor driving
performance. [16,17] Thus, a method able to measure the visual
function in varying contrast and glare conditions and in time-
dependent situations is needed.
The Central Vision Analyzer (CVA; Sinclair Technologies,
LLC, Media, PA) is a new interactive computer program to
analyze BCVA under conditions that simulate stressful and real-
world environments. [18,19] This backlight-glare computer-based
test for BCVA is able to simulate luminance, contrast, and glare
conditions that one may experience in a variety of daily activities,
such as glare, dim lighting, and night vision. Moreover, the CVA
testing is a time-dependent technique, yielding a better assessment
of real-life encounters. Therefore, it may be an ideal tool to assess
visual function and to understand the visual behavior under real-
life situations. The usefulness of this device has been tested in a
registered study at http://clinicaltrials.gov (identification, NCT
02028351), but results are not yet published.
The present study of PLWH aims to 1) assess visual acuity
measurements in simulated real-life situations using the CVA; 2)
correlate visual scores with RNFL thickness on spectral-domain
OCT; and 3) assess the best predictors of visual performance
under different light/contrast conditions using the CVA.
Methods
Subjects
This prospective, cross-sectional study included 89 eyes of 47
PLWH without active or healed retinitis and 105 eyes of 57 HIV-
seronegative adults (Table 1). The PLWH were part of a cohort
consecutively recruited from the University of California San
Diego (UCSD) AIDS Ocular Research Unit at the Jacobs Retina
Center in La Jolla, CA from June 2010 to June 2011. The PLWH
were recruited during the annual visit scheduled for research
purpose; none of the patients had any ocular symptoms at
enrollment. The HIV-seronegative individuals were recruited
from the local community. This study was approved by the UCSD
Human Research Protections Program and followed the tenets of
the Declaration of Helsinki. Signed informed consent was obtained
from all subjects before enrollment.
PLWH were divided into two groups based on the nadir CD4+
T-cell count. The high-nadir CD4 group maintained CD4+ T-cell
counts above 200 cells/mm3. From this group, 37 eyes from 19
persons were studied; 1 eye was excluded because of lens opacities.
The low-nadir CD4 group included PLWH with nadir CD4+ T-
cell counts lower than 200 cells/mm3 for at least 6 months in their
medical history. In this group, 52 eyes from 28 patients were
studied; 4 eyes were excluded because of a history of infectious
retinitis. All PLWH were taking ART for at least 6 months prior to
the time of the examination. The exclusion criteria included
history of ocular opportunistic infections; visible ocular abnormal-
ities on indirect ophthalmoscopy or slit-lamp ophthalmoscopy;
intraocular pressure 22 mmHg or higher; spherical equivalent
refractive error below 25 diopters or above +2.5 diopters; and
concurrent disease that could cause retinal damage, such as
diabetes or glaucoma. In the HIV-seronegative control group, 105
eyes from 57 volunteers were studied; 3 eyes were excluded
because of significant lens opacities; 6 eyes were excluded because
of macular pathology affecting vision.
Ocular Examination and Central Vision Analyzer Testing
All patients had a complete ocular examination, including
BCVA examination using standard ETDRS charts, slit-lamp
examination, intraocular pressure measurement, indirect ophthal-
moscopy under dilated pupils, and peripapillary RNFL thickness
measurement on Heidelberg Spectralis (Heidelberg Engineering,
Carlsbad, CA).
Before dilation, patients underwent CVA testing using a
Landolt C presentation of 900 msec in 6 different light/contrast
conditions (Table 1). The Landolt C appeared in three mesopic
conditions of 99% contrast against 3 Cd/m2 background (‘‘M1’’
module, that is full-contrast module of white letters presented on a
black background), followed by lower contrast modules of 64%
contrast (‘‘M2’’ module, simulating an environment similar to a
dimly lit restaurant) and 43% contrast (‘‘M3’’ module, simulating an
environment similar to driving at dusk). Photopic glare (backlight-
ing) conditions were simulated using 99% contrast against a 200
Cd/m2 background (‘‘G1’’ module, that is a full-contrast module of
black letters presented on a bright background), 10% contrast
(‘‘G2’’ module, simulating an environment similar to playing a sport
outside with the sun over head), and 8% contrast (‘‘G3’’ module,
simulating an environment similar to playing a sport outside with
the sun 15 degrees off-axis). The CVA displayed a tumbled
Landolt C in 4 different directions on a monitor positioned 4
meters from the patient, and to which the person responds by
pressing one of 4 buttons on a keypad (corresponding to the 4
different orientations). The program utilized a 0.05 logMAR
staircase of optotype size and thresholds for the smallest Landolt C
for which the person accurately identifies the tumbled position
twice with 2 inaccurate responses at the next smaller size. At the
end of the test, results were automatically presented to the
examiner in a report as six separate BCVA scores in logMAR units
for each of the simulated light/contrast conditions. [10].
Table 1. Characteristics of each of the CVA modules tested.
CVA modules Contrast (MC) Landolt C Luminance Background luminance Simulated Environment
Mesopic 1 (M1) 99% 220 Cd/m2 3 Cd/m2 Full contrast
Mesopic 2 (M2) 64% 4.8 Cd/m2 3 Cd/m2 Dim restaurant
Mesopic 3 (M3) 43% 8.4 Cd/m2 3 Cd/m2 Driving at dusk
Glare 1 (G1) 99% 1.6 Cd/m2 200 Cd/m2 Full contrast
Glare 2 (G2) 10% 180 Cd/m2 200 Cd/m2 Outside with sun over head
Glare 3 (G3) 8% 186 Cd/m2 200 Cd/m2 Outside with sun 15u off-axis
CVA, Central Vision Analyzer; MC, Michelson Contrast; Cd/m2, Candelas per Meter Squared.
doi:10.1371/journal.pone.0097023.t001
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Statistical Analysis
Mean age and duration of HIV were compared between HIV
groups using independent samples t-tests and chi-square tests were
used to test for gender differences between groups. Generalized
Estimating Equations (GEE) were used to compare LogMAR
BCVA and RNFL measures between HIV groups, adjusting for
gender. Bonferonni adjustments were made for multiple pairwise
comparisons. GEE was also used for the gender-adjusted
univariate and multivariate analyses, testing for the independent
association of HIV status and RNFL with logMAR BCVA.
Statistical analyses were performed using SAS statistical software
version 9.3 (SAS Inc, Cary, North Carolina, USA). A p-value ,
0.05 was considered to be statistically significant.
Results
Demographic and Disease Characteristics
At the time of examination, all 47 PLWH showed near-normal
immune status with ART. The mean CD4+ T-cell count was
6726281 cells/mm3 (range, 264–1,305 cells/mm3) and the mean
HIV plasma viral load was 24.9619.9 copies/mL (range, 0–50
copies/mL). Table 2 presents groups demographics. The two HIV
groups (i.e., low-nadir CD4 group and high-nadir CD4 group)
were similar for age (p= 0.66), as were the HIV-seropositive and
HIV-seronegative groups (p = 0.45). The HIV-seropositive group
included more men than women compared to the HIV-
seronegative group (p = 0.03). The duration of HIV disease was
similar between the two HIV groups (p = 0.62).
Assessment of Visual Acuity Measurements using the
Central Vision Analyzer
Comparing visual acuity measurements for various mesopic and
backlight-glare conditions among the 3 groups (Table 3), we found
statistically significant differences for ETDRS (p= 0.029), M1 (p,
0.001), M2 (p = 0.021) and M3 (p= 0.029), and G1 modules
(p = 0.001), after adjusting for gender. In particular, the high-nadir
CD4 group experienced worse visual scores than HIV-seronega-
tive subjects for ETDRS (p= 0.028) and G1 scores (p,0.001). The
low-nadir CD4 group experienced worse visual scores than HIV-
seronegative subjects for ETDRS (p= 0.058), M1 (p = 0.001), M2
(p = 0.012) and M3 (p= 0.021), and G1 modules (p,0.001). The
acuity drop between ETDRS and G1 was also significantly
different between groups (p = 0.005); in particular, it was greater in
the low-nadir CD4 group than in HIV-seronegative subjects
(p = 0.001). Among PLWH, the two groups had similar BCVA
scores (p.0.05). Gender-adjusted Spearman correlation coeffi-
cients with visual scores among PLWH showed that G1 scores
were correlated with vision decrease (p,0.001), while EDTRS
scores were not (p = 0.100). No significant correlation was found
between presumed duration of HIV and visual scores in any CVA
module.
In addition, we explored the hypothesis that the vision
dysfunction has a common pathway to neurophysiological
dysfunction. Changing the definition of low-nadir CD4 value
from 200 to 100 cells/mm3, statistical analysis showed more robust
results (data not shown); the high-nadir CD4 group (over 100
cells/mm3) experienced worse visual scores than HIV-seronegative
subjects not only for ETDRS (p= 0.039) and G1 scores (p,0.003)
as we described above, but also for M1 (p = 0.001), M2 (p= 0.014)
and M3 (p= 0.020).
T
a
b
le
2
.
D
e
m
o
g
ra
p
h
ic
s
o
f
St
u
d
y
P
ar
ti
ci
p
an
ts
.
V
a
ri
a
b
le
L
o
w
C
D
4
*
H
ig
h
C
D
4
p
-v
a
lu
e
H
IV
+
H
IV
2
p
-v
a
lu
e
T
o
ta
l
N
o
.
o
f
su
b
je
ct
s
2
8
1
9
4
7
5
7
1
0
4
N
o
.
o
f
e
ye
s
5
2
3
7
8
9
1
0
5
1
9
4
M
e
an
ag
e
(y
)
5
5
.1
5
3
.9
0
.6
6
T
5
4
.6
5
6
.2
0
.4
5
T
5
5
.5
A
g
e
ra
n
g
e
(y
)
4
1
–
8
5
4
4
–
7
3
4
1
–
8
5
2
8
–
8
4
2
8
–
8
5
M
e
n
(%
)
7
9
%
1
0
0
%
0
.0
3
C
8
7
%
6
8
%
0
.0
3
C
7
7
%
W
o
m
e
n
(%
)
2
1
%
0
%
1
3
%
3
2
%
2
3
%
D
u
ra
ti
o
n
o
f
H
IV
(y
)
1
8
.2
1
7
.0
0
.6
2
T
1
7
.7
n
/a
n
/a
Y
,
ye
ar
s;
n
/a
,
n
o
t
ap
p
lic
ab
le
;
*C
D
4
+
T
-c
e
ll
co
u
n
ts
lo
w
e
r
th
an
2
0
0
ce
lls
/m
m
3
fo
r
at
le
as
t
6
m
o
n
th
s
in
th
e
ir
m
e
d
ic
al
h
is
to
ry
;
T
=
In
d
e
p
e
n
d
e
n
t
sa
m
p
le
s
t-
te
st
;
C
=
C
h
i-
sq
u
ar
e
te
st
.
d
o
i:1
0
.1
3
7
1
/j
o
u
rn
al
.p
o
n
e
.0
0
9
7
0
2
3
.t
0
0
2
Visual Function in Simulated Real-Life Situations in HIV+ Subjects
PLOS ONE | www.plosone.org 3 May 2014 | Volume 9 | Issue 5 | e97023
T
a
b
le
3
.
A
n
al
ys
is
o
f
vi
su
al
ac
u
it
y
sc
o
re
s
b
e
tw
e
e
n
H
IV
-s
e
ro
n
e
g
at
iv
e
an
d
H
IV
-s
e
ro
p
o
si
ti
ve
p
at
ie
n
ts
,
ad
ju
st
e
d
fo
r
g
e
n
d
e
r.
H
IV
2
(5
7
)
H
IV
+
(4
7
)
H
IV
2
v
s
h
ig
h
C
D
4
H
IV
2
v
s
lo
w
C
D
4
H
ig
h
v
s
lo
w
C
D
4
B
C
V
A
(l
o
g
M
A
R
)
lo
w
C
D
4
(2
8
)
h
ig
h
C
D
4
(1
9
)
p
-v
a
lu
e
*
p
-v
a
lu
e
*
p
-v
a
lu
e
*
p
-v
a
lu
e
*
ET
D
R
S
Ls
m
ea
n
2
0
.0
6
7
2
0
.0
0
8
2
0
.0
1
5
0
.0
2
9
0
.0
2
8
0
.0
5
8
0
.8
4
3
SE
0
.0
1
3
0
.0
2
9
0
.0
1
9
M
1
Ls
m
ea
n
2
0
.0
4
3
0
.1
4
0
0
.1
2
9
,
0
.0
0
1
,
0
.0
0
1
0
.0
0
1
0
.8
6
3
SE
0
.0
2
0
.0
4
5
0
.0
4
6
M
2
Ls
m
ea
n
0
.1
9
4
0
.3
3
4
0
.3
0
9
0
.0
2
1
0
.0
7
8
0
.0
1
2
0
.7
3
6
SE
0
.0
3
0
0
.0
4
8
0
.0
5
7
M
3
Ls
m
ea
n
0
.3
1
3
0
.4
6
2
0
.4
3
4
0
.0
2
9
0
.0
7
0
0
.0
2
1
0
.7
2
6
SE
0
.0
3
3
0
.0
5
7
0
.0
5
7
G
1
Ls
m
ea
n
0
.0
1
8
0
.1
9
1
0
.1
0
2
0
.0
0
1
0
.1
6
1
,
0
.0
0
1
0
.1
9
5
SE
0
.0
2
6
0
.0
4
2
0
.0
5
3
G
2
Ls
m
ea
n
0
.3
5
4
0
.4
2
9
0
.3
9
9
0
.4
2
1
0
.4
4
4
0
.2
4
0
0
.6
9
9
SE
0
.0
2
8
0
.0
5
9
0
.0
4
9
G
3
Ls
m
ea
n
0
.4
4
6
0
.5
4
6
0
.4
5
6
0
.3
6
2
0
.8
8
5
0
.1
5
8
0
.2
9
1
SE
0
.0
3
5
0
.0
6
3
0
.0
5
5
ET
D
R
S
-
G
1
Ls
m
ea
n
2
0
.0
8
5
2
0
.1
9
9
2
0
.1
1
8
0
.0
0
5
0
.5
2
8
0
.0
0
1
0
.1
3
4
SE
0
.0
2
3
0
.0
2
7
0
.0
4
6
*A
p
p
ly
in
g
G
e
n
e
ra
liz
e
d
Es
ti
m
at
in
g
Eq
u
at
io
n
s
(G
EE
);
B
C
V
A
,
b
e
st
co
rr
e
ct
e
d
vi
su
al
ac
u
it
y;
SE
,
st
an
d
ar
d
e
rr
o
r;
ET
D
R
S,
Ea
rl
y
T
re
at
m
e
n
t
D
ia
b
e
ti
c
R
e
ti
n
o
p
at
h
y
St
u
d
y;
M
1
,
fu
ll-
co
n
tr
as
t
m
o
d
u
le
o
f
w
h
it
e
le
tt
e
rs
p
re
se
n
te
d
o
n
a
b
la
ck
b
ac
kg
ro
u
n
d
;M
2
,6
4
%
co
n
tr
as
t
m
o
d
u
le
si
m
u
la
ti
n
g
an
e
n
vi
ro
n
m
e
n
t
si
m
ila
r
to
a
d
im
ly
lit
re
st
au
ra
n
t;
M
3
,4
3
%
co
n
tr
as
t
m
o
d
u
le
si
m
u
la
ti
n
g
an
e
n
vi
ro
n
m
e
n
t
si
m
ila
r
to
d
ri
vi
n
g
at
d
u
sk
;G
1
,f
u
ll-
co
n
tr
as
t
m
o
d
u
le
o
f
b
la
ck
le
tt
e
rs
p
re
se
n
te
d
o
n
a
b
ri
g
h
t
b
ac
kg
ro
u
n
d
;
G
2
,
1
0
%
co
n
tr
as
t
m
o
d
u
le
si
m
u
la
ti
n
g
an
e
n
vi
ro
n
m
e
n
t
si
m
ila
r
to
p
la
yi
n
g
a
sp
o
rt
o
u
ts
id
e
w
it
h
th
e
su
n
o
ve
r
h
e
ad
;G
3
,8
%
co
n
tr
as
t
m
o
d
u
le
si
m
u
la
ti
n
g
an
e
n
vi
ro
n
m
e
n
t
si
m
ila
r
to
p
la
yi
n
g
a
sp
o
rt
o
u
ts
id
e
w
it
h
th
e
su
n
1
5
d
e
g
re
e
s
o
ff
-a
xi
s.
d
o
i:1
0
.1
3
7
1
/j
o
u
rn
al
.p
o
n
e
.0
0
9
7
0
2
3
.t
0
0
3
Visual Function in Simulated Real-Life Situations in HIV+ Subjects
PLOS ONE | www.plosone.org 4 May 2014 | Volume 9 | Issue 5 | e97023
Correlation of Visual Scores with RNFL Thickness on
Spectral-domain OCT
After correcting for gender (Table 4), the global peripapillary
RNFL thickness (‘‘G’’ value on the Heidelberg Spectralis) was
similar between groups (p = 0.353). The only RNFL sector that
showed difference between groups was the nasal-superior
(p = 0.039); the low-nadir CD4 group had thinner RNFL
compared the high-nadir CD4 group (p= 0.021) as well as
compared to HIV-seronegative subjects (p = 0.041). No correlation
was noted between duration of HIV disease and RNFL thickness.
Changing the definition of low-nadir CD4 value from 200 to
100 cells/mm3, statistical analysis showed more robust results (data
not shown); the global peripapillary RNFL thickness turned out to
be significantly different between groups (p = 0.032), and in
particular it was thinner in the low-nadir CD4 group compared
to HIV-seronegative subjects (p = 0.011).
Assessment of the Best Predictors of Visual Performance
Gender-adjusted univariate regression analysis (Table 5) con-
firmed that the HIV serostatus was highly associated with visual
scores for M1 (p,0.001), M2 (p = 0.006), M3 (p= 0.008), and G1
(p,0.001), as well as for ETDRS (p= 0.012). The global RNFL
thickness was associated with visual scores for M1 (p= 0.040), M2
(p = 0.018), and M3 (p= 0.005). The temporal-inferior RNFL
sector was the most associated to the vision performance: thinning
of temporal-inferior RNFL sector was associated to visual scores
for M1 (p= 0.033) and M2 modules (p = 0.016). A trend of
association was found between thinning of temporal-inferior
RNFL sector and visual scores for M3 (p= 0.064) and for ETDRS
(p= 0.065).
Gender-adjusted multivariate regression analysis (Table 5)
showed that HIV serostatus was the best predictor of visual
performance under different light/contrast conditions and corre-
lated well with ETDRS (p= 0.012), M1 (p,0.001), M2
(p = 0.031), M3 (p= 0.029), and G1 modules (p = 0.007). Thick-
ness of the temporal-inferior RNFL sector was also an indepen-
dent predictor of visual performance, especially for M1 (p= 0.033)
and M2 modules (p = 0.032).
Discussion
This study documented visual function abnormalities and
RNFL damage in PLWH without retinitis and confirmed findings
of other studies. PLWH have been reported to present reduced
contrast sensitivity, altered color vision, peripheral visual field loss
and electrophysiological changes [3–9]. In our study, the visual
function of HIV-seropositive and HIV-seronegative patients was
comprehensively analyzed in several contrast and luminance
conditions using a unique device – the Central Vision Analyzer –
that has been already approved by the Food And Drug
Administration. This new interactive computer program measures
logMAR visual acuity under conditions that simulate stressful and
real-world environments [18].
We demonstrated that visual scores are worse in PLWH in
comparison to HIV-seronegative subjects in most of the CVA
light/contrast conditions, especially if patients had history of nadir
CD4+ T-cell count lower than 100 cells/mm3. The HIV serostatus
turned out to be the best independent predictor of visual
performance under different light/contrast conditions. We have
already demonstrated that visual scores decline with decreasing
contrast and luminance conditions both in healthy eyes and in eyes
with macular pathology (Gomez ML, et al. IOVS 2011,52;ARVO
E-Abstract 5555). Moreover, in that study we found that the drop
in visual scores with decreasing light and contrast does not differ
between these two groups, even if the visual outcome is worse for
patients with macular pathology. In eyes with age-related macular
degeneration, damage of the outer retinal layers is the principal
cause of low visual outcomes. [20] In eyes of PLWH, visual
disturbances are mainly related to damage of the inner retinal
layers such as the RNFL, as detected by OCT, most likely due to
microinfarctions and microangiopathy. [10] In addition, recent
evidence has demonstrated a significant dysfunction of the outer
retinal layers in autopsy eyes of HIV-seropositive donors even in
the absence of infection or clinically apparent retinal lesions. [12]
Therefore we can conclude that the lower visual outcomes in eyes
of PLWH compared to HIV-seronegative controls may be related
to a combination of retinal dysfunctions, involving both inner and
outer retinal structures.
The luminance and contrast of the G1 module is the most
similar to that of the ETDRS chart test; however in PLWH we
found that the ETDRS chart test led to better visual acuity
compared to the G1 test. This finding is likely due to the time-
dependent nature of the automated CVA testing. Since the
EDTRS chart is not time-dependent, patients have indefinite time
to visualize letters on the chart; however this approach does not
mimic real-world situations. The CVA testing simulates stressful
and real-world environments, recreating light and contrast
conditions of time-dependent real life activities such as reading,
driving, or recognizing objects that are presented transiently.
Therefore, if letters are projected only for a short period of time,
patients with macular pathology may fail to recognize them since
they have slower reading speed than healthy patients. [21]
Similarly, PLWH may not be able to speedily recognize letters
because of HIV-related cognitive impairment, which is common
and can affect psychomotor speed and executive function. [22].
Although the nadir CD4+ T-cell count reflects the past severity
of the immune disease, in our study we did not find significantly
reduced visual scores in the low-nadir CD4 group compared to the
high-nadir CD4 group in any of the several light and contrast
conditions. Interestingly, the visual drop in high-contrast environ-
ments (i.e. ETDRS and G1) was also similar between HIV-
seropositive groups. Previous reports have described abnormalities
on visual field and multifocal electroretinogram (mfERG) in eyes
of PLWH in the absence of infectious retinitis; patients with
reduced immune status differed more from healthy eyes than eyes
from patients who never were observed to have reduced immune
status. [8,23] However, a subsequent study using more powerful
data analysis showed equal severity of b-latency abnormalities on
mfERG in the low- and high-CD4 groups. [24] The similarity of
mfERG abnormalities in the low- and high-nadir CD4 groups
[24], as well as the similar visual loss detected by the CVA as
described in the present study, indicates that good immune status
during ART may not protect against retinal damage. However, we
also can hypothesize that the immune status as indicated by the
nadir CD4+ T-cell count may not be the best predictor of visual
dysfunctions in HIV-positive subjects. Many other factors may be
implicated, such as current and highest HIV RNA level, duration
of HIV RNA suppression over time, number of opportunistic
infections, neurocognitive function, and also distribution of ART
drugs into the central nervous system. [25] Although we know the
date of diagnosis of HIV seropositivity, some patients on
presentation already had HIV for many years. This may explain
why we did not find correlations between duration of HIV
seropositivity and visual scores or RNFL thickness. A more
important predictor of visual performance and retinal damage
may be knowledge of the duration of low CD4+ T-cell counts and
uncontrolled HIV RNA. Such data is extremely difficult to
procure. Although we have some of these data on a small number
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of our patients at the moment, we do not have sufficient data for
our analysis. Therefore, in this pilot analysis, we included all
patients and classified them based on the limited data currently
available.
We also found thinning of the global peripapillary RNFL in the
low-nadir CD4 group compared to HIV-seronegative subjects, as
well as association between global RNFL and visual scores for
most CVA modules. Regression analysis indicated that the
temporal-inferior RNFL sector was the most associated sector
with visual performance in PLWH. This is consistent with previous
studies: a strong relationship was found between contrast
sensitivity and color vision with peripapillary RNFL in PLWH,
most apparent in the temporal quadrant. [26] These results are
biologically plausible; BCVA, contrast sensitivity, and color vision
are macular functions, and it is not surprising that correlations
were found primarily in the temporal RNFL, which reflects the
papillo-macular bundle. Because clinically we see a similar
distribution of cotton-wool spots in HIV-seropositive patients with
low-CD4 counts, we assume that these retinal microinfarctions are
at least one factor responsible for subsequent defects in RNFL
thickness. Indeed, histopathologic and tomographic studies
showed significance of cotton-wool spots in pathogenesis of retinal
neural tissue loss. [27,28].
There are a number of limitations to this study. Sample sizes
were relatively small, which may have affected our ability to
identify some potential associations. Certain components of study
participants’ medical history was self-reported and approximate,
such as date of HIV seroconversion, total number of opportunistic
infections, and ART duration and type over time. A comprehen-
sive analysis of ART is not possible in our population and might
prove extremely difficult because ART protocols are changed
frequently; longitudinal studies are necessary to assess the effect of
ART drugs on visual function. In addition, knowing the changes in
HIV RNA level overtime would be useful for further analysis.
Unfortunately, because of the long duration of HIV infection in
our study population (average duration: 17 years) and because of
the relatively recent referral to our center, we do not have precise
data on fluctuations of the HIV RNA level in our population. This
should be a topic of future studies. However, we found strong and
consistent results and we believe that it is unlikely that they would
be observed based on study deficiencies as opposed to real effects.
In conclusion, in our study we analyzed the visual function in
PLWH without active retinitis using a novel interactive computer
program that is able to test visual acuity in a variety of real-life
mesopic and glare conditions. We demonstrated that the HIV
status (positive vs negative) is the best independent predictor of
visual performance under different light/contrast conditions.
Visual function is more affected in PLWH in comparison to
HIV-seronegative subjects in varying contrast and luminance,
especially if patients had history of nadir CD4+ T-cell count lower
than 100 cells/mm3, and reflects the loss of RNFL thickness
especially of the temporal-inferior sector. This study confirms,
strengthens, and implements the previous finding that visual
function is affected in PLWH even in absence of retinitis. We
suggest paying particular attention while evaluating PLWH, even
if the immune system is near-normal at the time of examination,
because they may experience a greater visual dysfunction than
expected. The CVA, or a similar time-dependent vision testing,
may be of clinical use in the non-invasive diagnosis of early
subclinical HIV-associated visual dysfunction, and may offer better
understanding of this entity called ‘‘neuroretinal disorder’’.
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Table 5. Regression analyses of HIV status (seronegative vs seropositive) and retinal nerve fiber layers thickness with visual acuity,
adjusted for gender.
Univariate Multivariate
BCVA (logMAR) RNFL HIV status RNFL HIV status RNFL
p-value* p-value* p-value* p-value*
M1 ‘‘G’’ (global) ,0.001 0.040 ,0.001 0.055
Temp-Inf ,0.001 0.033 ,0.001 0.033
M2 ‘‘G’’ (global) 0.006 0.018 0.031 0.037
Temp-Inf 0.006 0.016 0.023 0.032
Temp-Sup 0.006 0.123 0.017 0.130
M3 ‘‘G’’ (global) 0.008 0.005 0.029 0.010
Temp-Inf 0.008 0.064 0.019 0.098
Nasal-Sup 0.008 0.076 0.021 0.117
G1 ‘‘G’’ (global) ,0.001 0.047 0.007 0.058
Nasal-Sup ,0.001 0.057 0.006 0.074
ETDRS ‘‘G’’ (global) 0.012 0.016 0.012 0.268
Temp-Inf 0.012 0.065 0.010 0.081
*Applying Generalized Estimating Equations (GEE); BCVA, best corrected visual acuity; RNFL, retinal nerve fiber layer; ETDRS, Early Treatment Diabetic Retinopathy Study;
M1, full-contrast module of white letters presented on a black background; M2, 64% contrast module simulating an environment similar to a dimly lit restaurant; M3,
43% contrast module simulating an environment similar to driving at dusk; G1, full-contrast module of black letters presented on a bright background.
doi:10.1371/journal.pone.0097023.t005
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